Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Life Sciences
ExxonMobil Completes Acquisition of Pioneer Natural Resources
Life Sciences Times
-
May 3, 2024
0
Venture Capital
Myonex Closes Creapharm Acquisition Expanding Global Services
Life Sciences Times
-
May 2, 2024
0
Venture Capital
Rippl acquires Boston based AI healthcare startup Kinto
Life Sciences Times
-
April 30, 2024
0
Venture Capital
Qlaris Bio Completes $24 Million Series B Financing Round to Advance QLS‑111, a First-in-class IOP-lowering Drug Candidate for Glaucoma
Life Sciences Times
-
April 30, 2024
0
Venture Capital
Enlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private Capital
Life Sciences Times
-
April 30, 2024
0
Venture Capital
908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
Life Sciences Times
-
April 30, 2024
0
Venture Capital
Carlin Consumer Health Acquires Penetrex from Wellbeam Consumer Health
Life Sciences Times
-
April 30, 2024
0
Venture Capital
ADAPTILENS ANNOUNCES $17.5M SERIES A FINANCING
Life Sciences Times
-
April 29, 2024
0
Venture Capital
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Life Sciences Times
-
April 29, 2024
0
Venture Capital
Manulife Investment Management Announces Forest Climate Fund’s Second Close Bringing Total Commitments Up to $334.5 Million
Life Sciences Times
-
April 26, 2024
0
Venture Capital
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing
Life Sciences Times
-
April 24, 2024
0
Venture Capital
Bruker to Acquire the NanoString Business in an Asset Deal
Life Sciences Times
-
April 22, 2024
0
1
...
31
32
33
...
115
Page 32 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026